ClinVar Genomic variation as it relates to human health
NM_000249.4(MLH1):c.2192dup (p.Pro731_Lys732insTer)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000249.4(MLH1):c.2192dup (p.Pro731_Lys732insTer)
Variation ID: 1787442 Accession: VCV001787442.2
- Type and length
-
Duplication, 1 bp
- Location
-
Cytogenetic: 3p22.2 3: 37050572-37050573 (GRCh38) [ NCBI UCSC ] 3: 37092063-37092064 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Nov 29, 2022 May 1, 2024 Jun 4, 2019 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000249.4:c.2192dup MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000240.1:p.Pro731_Lys732insTer frameshift NM_000249.3:c.2192dupC frameshift nonsense NM_001167617.3:c.1898dup NP_001161089.1:p.Pro633_Lys634insTer frameshift NM_001167618.3:c.1469dup NP_001161090.1:p.Pro490_Lys491insTer frameshift NM_001167619.3:c.1469dup NP_001161091.1:p.Pro490_Lys491insTer frameshift NM_001258271.2:c.1985dup NP_001245200.1:p.Pro662_Lys663insTer frameshift NM_001258273.2:c.1469dup NP_001245202.1:p.Pro490_Lys491insTer frameshift NM_001258274.3:c.1469dup NP_001245203.1:p.Pro490_Lys491insTer frameshift NM_001354615.2:c.1469dup NP_001341544.1:p.Pro490_Lys491insTer frameshift NM_001354616.2:c.1469dup NP_001341545.1:p.Pro490_Lys491insTer frameshift NM_001354617.2:c.1469dup NP_001341546.1:p.Pro490_Lys491insTer frameshift NM_001354618.2:c.1469dup NP_001341547.1:p.Pro490_Lys491insTer frameshift NM_001354619.2:c.1469dup NP_001341548.1:p.Pro490_Lys491insTer frameshift NM_001354620.2:c.1898dup NP_001341549.1:p.Pro633_Lys634insTer frameshift NM_001354621.2:c.1169dup NP_001341550.1:p.Pro390_Lys391insTer frameshift NM_001354622.2:c.1169dup NP_001341551.1:p.Pro390_Lys391insTer frameshift NM_001354623.2:c.1169dup NP_001341552.1:p.Pro390_Lys391insTer frameshift NM_001354624.2:c.1118dup NP_001341553.1:p.Pro373_Lys374insTer frameshift NM_001354625.2:c.1118dup NP_001341554.1:p.Pro373_Lys374insTer frameshift NM_001354626.2:c.1118dup NP_001341555.1:p.Pro373_Lys374insTer frameshift NM_001354627.2:c.1118dup NP_001341556.1:p.Pro373_Lys374insTer frameshift NM_001354628.2:c.2099dup NP_001341557.1:p.Pro700_Lys701insTer frameshift NM_001354629.2:c.2093dup NP_001341558.1:p.Pro698_Lys699insTer frameshift NM_001354630.2:c.2027dup NP_001341559.1:p.Pro676_Lys677insTer frameshift NC_000003.12:g.37050574dup NC_000003.11:g.37092065dup NG_007109.2:g.62225dup LRG_216:g.62225dup LRG_216t1:c.2192dup LRG_216p1:p.Lys732Terfs - Protein change
- -
- Other names
- -
- Canonical SPDI
- NC_000003.12:37050572:CC:CCC
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
MLH1 | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
5691 | 5752 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (1) |
criteria provided, single submitter
|
Jun 4, 2019 | RCV002425568.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Jun 04, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Hereditary cancer-predisposing syndrome
Affected status: unknown
Allele origin:
germline
|
Ambry Genetics
Accession: SCV002728569.2
First in ClinVar: Nov 29, 2022 Last updated: May 01, 2024 |
Comment:
The c.2192dupC pathogenic mutation (also known as p.K732*), located in coding exon 19 of the MLH1 gene, results from a duplication of C at nucleotide … (more)
The c.2192dupC pathogenic mutation (also known as p.K732*), located in coding exon 19 of the MLH1 gene, results from a duplication of C at nucleotide position 2192. This changes the amino acid from a lysine to a stop codon within coding exon 19. Another alteration resulting in the same stop codon (c.2194A>T) was reported in a woman of Czech ancestry who was diagnosed with colorectal cancer at age 37 and reportedly met Amsterdam criteria (Hajer J et al. Hum. Mutat. 2000 Aug;16(2):181), and in a Caucasian woman with a diagnosis of Muir-Torre syndrome due to metachronous colorectal, endometrial, gastric, and sebaceous carcinomas, all of which showed absence of MLH1 protein expression by IHC analysis (Svec J et al. Int. J. Clin. Exp. Pathol. 2014 Jul;7(8):5196-202). In addition to the clinical data presented in the literature, the c.2192dupC alteration is expected to result in loss of function by premature protein truncation. As such, this alteration is interpreted as a disease-causing mutation. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpThere are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar. |
Text-mined citations for this variant ...
HelpRecord last updated May 01, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.